Janssen has established itself as a market leader in the multiple myeloma treatment market through its comprehensive suite of janssen oncology products and pioneering janssen oncology drugs. The company's signature therapeutic offerings, especially Darzalex Faspro, are recognized as innovative multiple myeloma treatment drugs that emphasize patient-centric administration approaches....
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek
Bangla